Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Pharm-country symbols : Ecor save search
electroCore Expands Intellectual Property PortfolioelectroCore Granted Two New U.S. Patents
Published: 2024-04-02 (Crawled : 23:00) - biospace.com/
ECOR | $6.0 6.38% 6.0% 7.4K
|
Health Technology
|
| O: -1.63%
H: 0.0%
C: -2.16%
granted
electroCore, Inc. Announces gammaCore Non-Invasive Vagus Nerve Stimulator Available Through the Carrick Institute
Published: 2023-04-04 (Crawled : 18:00) - biospace.com/
ECOR | $6.0 6.38% 6.0% 7.4K
|
Health Technology
|
| O: -1.14%
H: 7.69%
C: 6.15%
electroCore Announces Fourth Quarter and Full Year 2022 Financial Results
Published: 2023-03-08 (Crawled : 01:00) - biospace.com/
ECOR | $6.0 6.38% 6.0% 7.4K
|
Health Technology
|
| O: 0.88%
H: 5.65%
C: 5.65%
year financial results
electroCore, Inc. Launches New Wellness Product Offering for Stress, Anxiety and Sleep, Truvaga™
Published: 2022-12-20 (Crawled : 17:00) - biospace.com/
ECOR | $6.0 6.38% 6.0% 7.4K
|
Health Technology
|
| O: 5.84%
H: 0.0%
C: -11.43%
offering wellness
electroCore Announces Issuance of Two New U.S. Patents
Published: 2022-12-07 (Crawled : 15:00) - biospace.com/
ECOR | $6.0 6.38% 6.0% 7.4K
|
Health Technology
|
| O: -2.26%
H: 11.08%
C: -16.67%
gammaCore (Non-Invasive Vagus Nerve Stimulation; nVNS) Reduces Symptoms of Acute Withdrawal in Patients with Opioid Use Disorder
Published: 2022-09-07 (Crawled : 14:00) - biospace.com/
ECOR | $6.0 6.38% 6.0% 7.4K
|
Health Technology
|
| O: 0.0%
H: 5.0%
C: 4.14%
opioid
electroCore, Inc. Announces gammaCore™ Non-Invasive Vagus Nerve Stimulator Available Through National Spine and Pain Centers
Published: 2022-05-24 (Crawled : 16:00) - biospace.com/
ECOR | $6.0 6.38% 6.0% 7.4K
|
Health Technology
|
| O: -3.01%
H: 2.86%
C: -3.64%
spine
electroCore to Announce First Quarter 2022 Financial Results on May 5
Published: 2022-04-28 (Crawled : 20:00) - biospace.com/
ECOR | $6.0 6.38% 6.0% 7.4K
|
Health Technology
|
| O: 2.06%
H: 0.52%
C: -14.04%
results
gammaCore™ Non-Invasive Vagus Nerve Stimulation (nVNS) Selected for Department of Defense Biotech Optimized for Operational Solutions and Tactics (BOOST) Program
Published: 2022-04-19 (Crawled : 14:00) - biospace.com/
ECOR | $6.0 6.38% 6.0% 7.4K
|
Health Technology
|
| O: -0.77%
H: 3.74%
C: 0.8%
solutions defense biotech program
electroCore Announces Fourth Quarter and Full Year 2021 Financial Results
Published: 2022-03-10 (Crawled : 23:00) - biospace.com/
ECOR | $6.0 6.38% 6.0% 7.4K
|
Health Technology
|
| O: -2.05%
H: 8.13%
C: -0.17%
financial results ces results
electroCore, Inc. Announces Completion of Enrollment in the TRANSIT Study of non-Invasive Vagus Nerve Stimulation (nVNS) in Post-Operative Ileus
Published: 2022-02-01 (Crawled : 14:00) - biospace.com/
ECOR | $6.0 6.38% 6.0% 7.4K
|
Health Technology
|
| O: 2.99%
H: 3.33%
C: 1.45%
enroll
gammaCore™ Non-Invasive Vagus Nerve Stimulation(nVNS) Receives Breakthrough Device Designation for Treatment of Posttraumatic Stress Disorder (PTSD)
Published: 2022-01-12 (Crawled : 14:00) - biospace.com/
ECOR | $6.0 6.38% 6.0% 7.4K
|
Health Technology
|
| O: 4.27%
H: 70.91%
C: 53.47%
treatment designation
electroCore, Inc. Provides Update on nVNS to Treat Post Traumatic Stress Disorder
Published: 2021-12-14 (Crawled : 15:30) - biospace.com/
ECOR | $6.0 6.38% 6.0% 7.4K
|
Health Technology
|
| O: -5.91%
H: 1.38%
C: -4.44%
order
electroCore to Participate at Canaccord Genuity MedTech & Diagnostics Forum
Published: 2021-11-11 (Crawled : 16:00) - biospace.com/
ECOR | $6.0 6.38% 6.0% 7.4K
|
Health Technology
|
| O: 2.71%
H: 0.93%
C: -1.79%
diagnostics diagnostic
electroCore Announces Open Access and Submission of Manuscript from SAVIOR-1 study of Non-Invasive Vagus Nerve Stimulation (nVNS) in Hospitalized COVID-19 Patients
Published: 2021-09-29 (Crawled : 14:00) - biospace.com/
ECOR | $6.0 6.38% 6.0% 7.4K
|
Health Technology
|
| O: 3.57%
H: 0.86%
C: -3.45%
covid submission
Study of Non-Invasive Vagus Nerve Stimulation (nVNS) Shows Improvement in PTSD Symptoms and Decreased Inflammatory Response to Stress
Published: 2021-08-10 (Crawled : 13:00) - biospace.com/
ECOR | $6.0 6.38% 6.0% 7.4K
|
Health Technology
|
| O: 1.9%
H: 0.93%
C: -1.87%
response
electroCore Supports Results of Lancet Paper Highlighting the Benefits of Vagus Nerve Stimulation for Stroke Patients
Published: 2021-05-18 (Crawled : 18:00) - biospace.com/
ECOR | $6.0 6.38% 6.0% 7.4K
|
Health Technology
|
| O: 1.29%
H: 6.37%
C: 3.18%
stroke results lancet
electroCore Announces Publication in Nature Reviews: Neurology Highlighting the Role of Non-Invasive Vagus Nerve Stimulation (nVNS) as an Emerging Treatment for Cluster Headache
Published: 2021-04-15 (Crawled : 14:00) - biospace.com/
ECOR | $6.0 6.38% 6.0% 7.4K
|
Health Technology
|
| O: 1.1%
H: 0.16%
C: -4.35%
treatment
Chief Medical Officer of electroCore, Inc. Peter Staats, M.D. Describes Potential At-Home Solutions to Reduce Common COVID-19 Symptoms
Published: 2021-03-15 (Crawled : 14:00) - biospace.com/
ECOR | $6.0 6.38% 6.0% 7.4K
|
Health Technology
|
| O: 0.0%
H: 3.74%
C: 2.8%
covid potential
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.